HMVAB41

Details HMVAB41 HMVAB41

1997-11-26

1999-08-03

Campell, Bruce R.

Chemistry: molecular biology and microbiology

Micro-organism, tissue cell culture or enzyme using process...

Recombinant dna technique included in method of making a...

4353201, 435325, 4352523, 43525411, 435440, 536 231, 536 235, C12N 510, C12N 1512, C12N 1563, C07H 2100

Patent

active

059324465

ABSTRACT:
HMVAB41 polypeptides and polynucleotides and methods for producing such polypeptides by recombinant techniques are disclosed. Also disclosed are methods for utilizing HMVAB41 polypeptides and polynucleotides in the design of protocols for the treatment of cancer, inflammation, autoimmunity, allergy, asthma, rheumatoid arthritis, CNS inflammation, cerebellar degeneration, Alzheimer's disease, Parkison's disease, multiple sclerosis, amylotrophic lateral sclerosis, head injury damage, and other neurological abnormalities, septic shock, sepsis, stroke, osteoporosis, osteoarthritis, ischemia reperfusion injury, cardiovascular disease, kidney disease, liver disease, ischemic injury, myocardial infarction, hypotension, hypertension, AIDS, myelodysplastic syndromes and other hematologic abnormalities, aplastic anemia, male pattern bladness, and bacterial, fungal, protozoan and viral infections, among others, and diagnostic assays for such conditions.

REFERENCES:
Human Genome Sciences Corporation EST # 1583776.

Affiliated with

Also associated with

Rating

HMVAB41 does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with HMVAB41, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and HMVAB41 will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-848820